User profiles for Elie Haddad
Elie HaddadCHU Sainte-Justine ou Université de Montréal ou University of Montreal ou INSERM ou … Verified email at umontreal.ca Cited by 15729 |
Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family
…, H Vitzthum, K Klingel, M Kratz, E Haddad… - Nature …, 2002 - nature.com
Magnesium is an essential ion involved in many biochemical and physiological processes.
Homeostasis of magnesium levels is tightly regulated and depends on the balance between …
Homeostasis of magnesium levels is tightly regulated and depends on the balance between …
Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients
Objective: To evaluate the outcome of children who received prolonged intravenous
immunoglobulin (IVIg) replacement therapy early in life for X-linked agammaglobulinemia (XLA). …
immunoglobulin (IVIg) replacement therapy early in life for X-linked agammaglobulinemia (XLA). …
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
…, IC Hanson, N Kapoor, E Haddad… - Blood, The Journal …, 2011 - ashpublications.org
X-linked lymphoproliferative disease (XLP1) is a rare immunodeficiency characterized by
severe immune dysregulation and caused by mutations in the SH2D1A/SAP gene. Clinical …
severe immune dysregulation and caused by mutations in the SH2D1A/SAP gene. Clinical …
[HTML][HTML] Transplantation outcomes for severe combined immunodeficiency, 2000–2009
…, KW Chan, RL Fuleihan, E Haddad… - … England Journal of …, 2014 - Mass Medical Soc
Background The Primary Immune Deficiency Treatment Consortium was formed to analyze
the results of hematopoietic-cell transplantation in children with severe combined …
the results of hematopoietic-cell transplantation in children with severe combined …
Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe condition that
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …
follows benign COVID-19. We report autosomal recessive deficiencies of OAS1, OAS2, or …
Noncoding regions are the main source of targetable tumor-specific antigens
…, J Lanoix, S Vobecky, E Haddad… - Science translational …, 2018 - science.org
Tumor-specific antigens (TSAs) represent ideal targets for cancer immunotherapy, but few
have been identified thus far. We therefore developed a proteogenomic approach to enable …
have been identified thus far. We therefore developed a proteogenomic approach to enable …
Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients
S Dupuis-Girod, J Medioni, E Haddad, P Quartier… - …, 2003 - publications.aap.org
Objectives. To evaluate the occurrence of autoimmune and inflammatory complications in
Wiskott-Aldrich syndrome (WAS) and to determine risk factors and the prognosis of such …
Wiskott-Aldrich syndrome (WAS) and to determine risk factors and the prognosis of such …
Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre …
…, U Schanz, R Seger, K Rentsch, P Veys, E Haddad… - The Lancet, 2014 - thelancet.com
Background In chronic granulomatous disease allogeneic haemopoietic stem-cell
transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is …
transplantation (HSCT) in adolescents and young adults and patients with high-risk disease is …
Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980 …
In this retrospective collaborative study, we have analyzed long-term outcome and donor cell
engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been treated …
engraftment in 194 patients with Wiskott-Aldrich syndrome (WAS) who have been treated …
[PDF][PDF] Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike
…, A Benoit, V Loungnarath, G Brochu, E Haddad… - Cell Reports …, 2020 - cell.com
SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic, infecting
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …